Samba-02: An Investigation of the Dose-Response and Subject Variability of Inhaled Insulin in Subjects With Type 2 Diabetes

Trial Profile

Samba-02: An Investigation of the Dose-Response and Subject Variability of Inhaled Insulin in Subjects With Type 2 Diabetes

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Mar 2016

At a glance

  • Drugs Insulin (Primary) ; Insulin lispro
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms Samba-02
  • Sponsors Dance Biopharm
  • Most Recent Events

    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 21 Jun 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
    • 17 Oct 2013 New source identified and integrated: European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top